Get the Weekly Intelligence Brief — top committee picks every Sunday.

FRPT vs INGR

Freshpet, Inc. vs Ingredion — AI-powered side-by-side comparison
FRPT
Freshpet, Inc.
61
Buy
VS
INGR
Ingredion
62
Buy
MetricFRPTINGR
AI Score 61 62
Price $71.67 $104.70
P/E Ratio 17.25× 11.25×
ROE 11.5% 16.8%
Revenue Growth YoY
Gross Margin 39.3% 23.7%
Debt / Equity 0.40× 0.39×
Dividend Yield 0.0% 3.1%
RSI (14) 74.2 57.8
Beta 1.639 0.606
Expected Upside +1.6%

AI Committee View

Current Innellis committee reasoning for FRPT versus INGR.
INGR leads by 1 points.

INGR scores 62/100 (Buy) versus FRPT at 61/100 (Buy).

FRPT Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 32.3% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 16.7% shows genuine earnings power backing the valuation — Value
  • EPS growing 449.7% YoY — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • RSI at 74 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
  • Bollinger bandwidth of 32.3% signals elevated volatility — Risk
INGR Committee View
60% agreement
5 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is revenue declining -1.4% yoy -- this is not a growth story right now. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 11.1 is inexpensive for the broad market — Value
  • Dividend yield of 3.2% pays you to wait — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Revenue declining -1.4% YoY -- this is not a growth story right now — Growth
  • EPS declining -10.3% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
FRPT Full Analysis INGR Full Analysis